Details for Patent: 12,590,068

Which drugs does patent 12,590,068 protect, and when does it expire?

Patent 12,590,068 protects ORLADEYO and is included in two NDAs.

This patent has twenty-four patent family members in twenty-one countries.

Drugs Protected by US Patent 12,590,068

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Biocryst	ORLADEYO	berotralstat dihydrochloride	CAPSULE;ORAL	214094-001	Dec 3, 2020		RX	Yes	No	12,590,068		Y	Y
Biocryst	ORLADEYO	berotralstat dihydrochloride	CAPSULE;ORAL	214094-002	Dec 3, 2020		RX	Yes	Yes	12,590,068		Y	Y
Biocryst	ORLADEYO	berotralstat dihydrochloride	PELLETS;ORAL	219776-001	Dec 11, 2025		RX	Yes	No	12,590,068		Y	Y

International Family Members for US Patent 12,590,068

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	116951
Australia	2019374115
Brazil	112021008249